Does double trigger (GnRH-agonist plus hCG) improve outcome in poor responders undergoing IVF-ET cycle? A pilot study
Does double trigger (GnRH-agonist plus hCG) improve outcome in poor responders undergoing IVF-ET cycle? A pilot study
复制标题
DOI:
10.1080/09513590.2019.1576621
复制
发表时间:
2019-07-03
影响因子:
2
通讯作者:
Orvieto, Raoul
中科院分区:
文献类型:
--
作者:
Haas, Jigal;Zilberberg, Eran;Orvieto, Raoul
Many strategies are offered for the treatment of poor responders. However, no compelling advantage for one stimulation protocol over another has been hitherto established. In this study, we aimed to evaluate the role of different modes and timings of final follicular maturation trigger, on in vitro fertilization (IVF) cycle outcome of poor responder patients. In the present randomized controlled study, poor responder patients, according to the Bologna criteria, undergoing controlled ovarian hyperstimulation (COH) using the gonadotropin-releasing hormone (GnRH) antagonist protocol were randomly assigned to three different final follicular maturation trigger modes and timings: hCG 36h before oocyte pick-up (OPU) (hCG trigger); GnRH agonist (GnRHag) 36h before (OPU) and hCG on day of OPU (GnRHag trigger); and GnRHag and hCG, 40 and 34h prior to OPU, respectively (double trigger). Pregnancy rate, number of oocytes, and top quality embryos (TQEs). Thirty-three poor responder patients were recruited and randomized to the different study groups. While there were no in-between groups' differences in patients' demographics and stimulation variables, patients in the double trigger group had a significantly higher number of TQE (1.10.9 vs. 0.30.8 and 0.5+0.7; p